196 related articles for article (PubMed ID: 17823140)
1. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of epoetin alfa in critically ill patients.
Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ;
N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic agents for anemia of critical illness.
Shermock KM; Horn E; Rice TL
Am J Health Syst Pharm; 2008 Mar; 65(6):540-6. PubMed ID: 18319499
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
6. Is there a place for epoetin alfa in managing anemia during critical illness?
Givens M; Lapointe M
Clin Ther; 2004 Jun; 26(6):819-29. PubMed ID: 15262453
[TBL] [Abstract][Full Text] [Related]
7. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
[TBL] [Abstract][Full Text] [Related]
9. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
10. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
Hua F; Xie H; Worthington HV; Furness S; Zhang Q; Li C
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008367. PubMed ID: 27778318
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD; Allen IE; Henry DH; Seaman C; Sercus B; Goodnough LT
Clin Ther; 2006 Jun; 28(6):801-31. PubMed ID: 16860166
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Bohlius J; Schmidlin K; Brillant C; Schwarzer G; Trelle S; Seidenfeld J; Zwahlen M; Clarke MJ; Weingart O; Kluge S; Piper M; Napoli M; Rades D; Steensma D; Djulbegovic B; Fey MF; Ray-Coquard I; Moebus V; Thomas G; Untch M; Schumacher M; Egger M; Engert A
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007303. PubMed ID: 19588423
[TBL] [Abstract][Full Text] [Related]
13. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
14. Epoetin alfa protocol and multidisciplinary blood-conservation program for critically ill patients.
Pell LJ; Martin BS; Shirk MB
Am J Health Syst Pharm; 2005 Feb; 62(4):400-5. PubMed ID: 15745893
[TBL] [Abstract][Full Text] [Related]
15. Blood conservation in the critically ill.
Thomas J; Martinez A
Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S11-8. PubMed ID: 17687066
[TBL] [Abstract][Full Text] [Related]
16. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher S; Ohlsson A
Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin use in intensive care.
Darveau M; Notebaert E; Denault AY; Bélisle S
Ann Pharmacother; 2002 Jun; 36(6):1068-74. PubMed ID: 12022910
[TBL] [Abstract][Full Text] [Related]
18. Use of epoetin alfa in critically ill patients.
Pajoumand M; Erstad BL; Camamo JM
Ann Pharmacother; 2004 Apr; 38(4):641-8. PubMed ID: 14966258
[TBL] [Abstract][Full Text] [Related]
19. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S
Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759
[TBL] [Abstract][Full Text] [Related]
20. Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation.
Rose L; Adhikari NK; Leasa D; Fergusson DA; McKim D
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011833. PubMed ID: 28075489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
